Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function

Fig. 2

Changes of anti-HBs levels within groups and cell subsets in non-vaccine group. Comparison of anti-HBs levels at different time points in Vaccine group and non-vaccine group (A). Changes in proportion of cell subsets and the expression of surface cytokines in non-vaccine group (B). The statistical analysis of changes in anti-HBs was determined by Wilcoxon matched-pairs signed-rank test. The statistical analysis of changes in cell subsets was determined by independent sample t-test. *p < 0.05; **p < 0.005; ***p < 0.001

Back to article page